Prescriptions as a proxy for asthma in children: a good choice?
- 111 Downloads
Stock et al. (Eur Respir J 25:47–53, 2005) recently estimated asthma prevalence in Germany using claims data on prescriptions and hospital diagnoses and found high prevalence peaks in infants. Our objective was to critically assess and discuss various aspects of identifying children with asthma using prescription data.
We replicated the selection procedure of Stock et al. using data on 290,919 children aged 0–17 years insured in the Gmünder ErsatzKasse (GEK) in 2005. Asthma prevalence was also estimated in a sample of 17,641 children aged 0–17 years participating in the German Health Interview and Examination Survey for Children and Adolescents (KiGGS) from 2003 to 2006.
In children aged 0–4 years insured in the GEK, prevalences were found to range from 11.7 to 17.7% for boys and from 7.2 to 11.1% for girls when the criteria of Stock et al. were applied. A steady decline in prevalences was observed in older age groups. Asthma prevalence estimated in the KiGGS data showed a quite different distribution. In the age group 0–4 years, prevalences were found to range from 0 to 2.6% in boys and from 0 to 1.0% in girls; in children >4 years, prevalences were found to increase with increasing age.
When additional validation studies were taken into account, asthma medications were found to be prescribed not only for asthma but also for other respiratory diseases. In addition, not all children with current asthma had prescriptions. We therefore conclude that asthma medications are therefore not a good proxy for the disease.
KeywordsAsthma Children Claims data Cross-sectional study Prevalence
This study was not supported by any institution. We thank the Gmünder ErsatzKasse (GEK) for providing the data.
Conflict of interests
FH and GG received funding to analyze the data of several health insurance companies, including those of the GEK.
- 1.Bacharier LB, Boner A, Carlsen KH, Eigenmann PA, Frischer T, Götz M, Helms PJ, Hunt J, Liu A, Papadopoulos N, Platts-Mills T, Pohunek P, Simons FE, Valovirta E, Wahn U, Wildhaber J, European Pediatric Asthma Group (2008) Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report. Allergy 63:5–34CrossRefPubMedGoogle Scholar
- 2.Global Initiative for Asthma (2005) Global strategy for asthma management and prevention. National Heart, Lung and Blood Institute, NIH, BethesdaGoogle Scholar
- 5.Barbato A, Panizzolo C, Biserna L, Cantarutti L, Giaquinto C, Frati F, Marcucci F, Monciotti C, Testi R, di Blasi P, Sturkenboom MC, Pedianet Family Pediatricians Asthma Study Group (F-PASG) (2003) Asthma prevalence and drug prescription in asthmatic children. Eur Ann Allergy Clin Immunol 35:47–51PubMedGoogle Scholar
- 8.Public-Use-File KiGGS (2008) Kinder- und Jugendgesundheitssurvey 2003–2006. Robert Koch-Institut, BerlinGoogle Scholar
- 9.Kurth BM, Kamtsiuris P, Hölling H, Schlaud M, Dölle R, Ellert U, Kahl H, Knopf H, Lange M, Mensink GB, Neuhauser H, Rosario AS, Scheidt-Nave C, Schenk L, Schlack R, Stolzenberg H, Thamm M, Thierfelder W, Wolf U (2008) The challenge of comprehensively mapping children’s health in a nation-wide health survey: design of the German KiGGS-Study. BMC Public Health 8:196CrossRefPubMedGoogle Scholar
- 11.Grobe TG, Dörning H, Schwartz FW (2008) GEK-Report ambulant-ärztliche Versorgung 2008. St. Augustin, AsgardGoogle Scholar
- 20.BTS/SIGN (2008) British guideline on the management of asthma. Available at: www.sign.ac.uk/pdf/sign101.pdf. Accessed 7 July 2009
- 22.Global Initiative for Chronic Obstructive Lung Disease (GOLD) (2007) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Updated 2007. Executive Summary. Available at: http://www.goldcopd.com/Guidelineitem.asp?l1=2&l2=1&intId=996. Accessed 7 July 2009
- 23.Magnus P, Jaakkola JJ (1997) Secular trend in the occurrence of asthma among children and young adults: critical appraisal of repeated cross sectional surveys. Br Med J 314:1795–1799Google Scholar